{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-randomised-double-blind-placebo-controlled-phase-iii-study-of-adjuvant-saruparib-azd5305-in-patients-with-brcam-localised-high-risk-prostate-cancer-receiving-radiotherapy-with-androgen-deprivat\/#breadcrumbitem"}]}